The use of sirtex in inoperable liver tumours. A surgeon's view

Liver and Biliary Tract Surgery: Embryological Anatomy to 3D-Imaging and Transplant Innovations

Volumn , Issue , 2006, Pages 419-420

  Zacharoulis, D ^a,b   Habib, N A ^b   Jiao, R ^b  

^a UNIVERSITY OF THESSALY   (Greece)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79951964242     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-211-49277-2_35     Document Type: Chapter

References (7)

1. Andrews JC, alker SC, Ackermann RJ, Cotton LA, and et al. Hepatic radioembolization with yttrium-90 containing glass microspheres: Preliminary results and clinical follow-up [comment]. Journal of Nuclear Medicine 35, 1994; 1637-44.
2. Ho S, Lau WY, Leung TW, and Chan M et al. Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. European Journal of Nuclear Medicine 24, 1997; 293-8.
3. Lau WY, Ho S, Leung TWT, and Chan M et al. Selective internal radiation therapy for non-resectable hepatocellular carcinoma with intra-arterial infusion of 90yttrium microspheres. International Journal of Radiation Oncology Biology Physics 40, 1998; 583-92.
4. Stubbs RS, annan RJ, and itchell AW. Selective internal radiation therapy with 90 yttrium microspheres for extensive colorectal liver metastases. Journal of Gastrointestinal Surgery 5, 2001; 294-302.
5. Gray B, Van Hazel G, Hope M, Burton M, and et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Annals of Oncology 12, 2001; 1711-20.
6. Herba MJ and Thirlwell MP. Radioembolization for hepatic metastases. Seminars in Oncology 29, 2002; 152-159.
7. Ayav A, Habib N, Jiao LR. Portal hypertension secondary to 90Yttrium microspheres: An unknown complication. J Clin Onco123: 2005; 8275-6.